点眼薬の世界市場レポート 2025年

点眼薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.7％で193億3,000万米ドルに成長します。予測期間の成長は、目に関連する疾患の有病率の上昇、公衆衛生への取り組み、精密医薬品や個別化医薬品の使用の増加、消費者教育への取り組み、研究開発に起因すると考えられます。予測期間の主な動向としては、ナノ粒子ベースの薬剤製剤、先進ドラッグデリバリーシステム、革新的なドラッグデリバリーの重視、革新的ソリューションのための共同作業、複数回投与点眼器の需要急増などが挙げられます。

予測される眼障害の増加は、当面の点眼薬市場の拡大を牽引するものと思われます。眼疾患には、視力障害や不快感につながる、眼に影響を及ぼすさまざまな病状が含まれます。これらの疾患の有病率の増加は、環境要因、コンタクトレンズ使用の増加、ライフスタイルの変化、男女格差、必須ビタミンの欠乏などに起因しています。眼科用スポイトは、様々な眼の症状を治療するために、正確な量の薬剤を眼に直接投与する上で重要な役割を果たしています。例えば、2024年1月現在、40歳以上のアメリカ人のうち340万人以上が失明または視覚障害者であると疾病管理予防センターは報告しており、この数字は2030年までに倍増すると予測されています。したがって、眼障害の有病率の上昇が点眼薬市場の拡大に拍車をかけています。

点眼薬市場の有力企業は、製品の有効性と安全性を高めるため、抗菌性眼科用スポイトなどの先駆的ソリューションに注力しています。抗菌技術と統合されたこれらのスポイトは、眼科治療のための無菌で衛生的なアプリケーションを保証します。例えば、2022年3月、PyloteとBerry Global Group Inc.は抗菌点眼スポイトを発表しました。この革新的なスポイトは、パイロテの特許取得済みのミネラル抗菌技術とベリー世界の持続可能なヘルスケアパッケージの専門知識を組み合わせたものです。先端に抗菌技術を組み込むことで、使用するたびに衛生的な使用を保証し、従来の単回投与ソリューションと比較してプラスチック廃棄物も削減します。さらに、既存の治療や包装プロセスとの互換性も維持しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界点眼薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の点眼薬市場：成長率分析
• 世界の点眼薬市場の実績：規模と成長, 2019-2024
• 世界の点眼薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界点眼薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の点眼薬市場スポイトで、実績と予測, 2019-2024, 2024-2029F, 2034F
• ユニドーズ点眼薬
• プリザーブドマルチドーズスポイト
• 防腐剤不使用のマルチドーズ点眼器
• 世界の点眼薬市場薬剤の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 処方薬
• 市販薬（OTC）
• 世界の点眼薬市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ドライアイ
• 緑内障
• アレルギー
• 結膜炎
• その他の治療タイプ
• 世界の点眼薬市場：最終用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 眼科センター
• 在宅ケア設定
• その他のエンドユーザー
• 世界の点眼薬市場ユニドーズ点眼薬のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 使い捨て容器
• 使い捨てスポイトシステム
• 世界の点眼薬市場、保存された多回投与点眼器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 防腐剤入り点眼薬
• 保存容器を内蔵した多回分容器
• 世界の点眼薬市場防腐剤不使用のマルチドーズ点眼器の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 防腐剤不使用の多回分容器
• 防腐剤不使用、滅菌点眼システム

第7章 地域別・国別分析

• 世界の点眼薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の点眼薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 点眼薬市場：競合情勢
• 点眼薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bausch & Lomb Incorporated Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Rexam Healthcare Packaging Inc.
• Intas Pharmaceuticals Ltd.
• AptarGroup Inc
• Cipla Ltd
• Gerresheimer AG
• Lupin Ltd.
• Santen Pharmaceutical Co Ltd.
• Rohto Pharmaceutical Co Ltd.
• Silgan Dispensing Systems
• Akorn Operating Company LLC
• Nemera Development S.A.
• Ajanta Pharma Ltd.
• Perrigo Company plc
• Bora Pharmaceuticals Co Ltd.
• Sun Pharmaceutical Industries Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 点眼薬市場2029：新たな機会を提供する国
• 点眼薬市場2029：新たな機会を提供するセグメント
• 点眼薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

An ophthalmic eye dropper is a medical device specifically designed for administering liquid medication, usually in the form of eye drops, into the eyes. It is used by gently squeezing the bottle to release a drop into the lower eyelid pocket, ensuring precise administration of the medication into the eye.

The main types of ophthalmic eye droppers include unidose eye droppers, preserved multi-dose eye droppers, and preservative-free multi-dose eye droppers. A unidose eye dropper is a single-use, pre-measured container designed to deliver a specific dose of eye drops. Various drugs, including prescription and over-the-counter (OTC) medications, are used to treat conditions such as dry eye, glaucoma, allergies, conjunctivitis, and others, and are utilized in hospitals, ophthalmic centers, homecare settings, and other locations.

The ophthalmic eye dropper research report is one of a series of new reports from The Business Research Company that provides ophthalmic eye dropper market statistics, including the ophthalmic eye dropper industry's global market size, regional shares, competitors with an ophthalmic eye dropper market share, detailed ophthalmic eye dropper market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic eye dropper industry. This ophthalmic eye dropper market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ophthalmic eye dropper market size has grown strongly in recent years. It will grow from $13.32 billion in 2024 to $14.38 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to enhanced patient convenience, favorable regulatory environment, adoption of combination therapies, shift towards combination therapies, and preference for self-administered eye care products.

The ophthalmic eye dropper market size is expected to see strong growth in the next few years. It will grow to $19.33 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to the rising prevalence of eye-related conditions, public health initiatives, increasing use of precision and individualized medicines, consumer education initiatives, and research and development. Major trends in the forecast period include nanoparticle-based drug formulations, advanced drug delivery systems, emphasis on innovative drug delivery, collaborative efforts for innovative solutions, and a surge in demand for multi-dose eye droppers.

The anticipated rise in eye disorders is set to drive the expansion of the ophthalmic eye dropper market in the foreseeable future. Eye disorders encompass a wide range of medical conditions affecting the eyes, leading to vision impairment or discomfort. The growing prevalence of these disorders can be attributed to environmental factors, increased contact lens usage, shifts in lifestyle, gender disparities, and deficiencies in essential vitamins. Ophthalmic eye droppers play a crucial role in delivering precise doses of medication directly to the eyes for treating various eye conditions. For example, as of January 2024, the Centers for Disease Control and Prevention reported that over 3.4 million Americans aged 40 and above were either blind or visually impaired, a figure projected to double by 2030. Hence, the escalating prevalence of eye disorders is fueling the expansion of the ophthalmic eye dropper market.

Prominent players in the ophthalmic eye dropper market are concentrating on pioneering solutions, such as antimicrobial ophthalmic droppers, to enhance product efficacy and safety. These droppers, integrated with antimicrobial technology, ensure sterile and hygienic application for eye treatments. For instance, in March 2022, Pylote and Berry Global Group Inc. unveiled an antimicrobial ophthalmic dropper, aiming to introduce the first multidose dropper with antimicrobial protection. This innovative dropper combines Pylote's patented mineral antimicrobial technology with Berry Global's expertise in sustainable healthcare packaging. It incorporates antimicrobial technology at the tip, ensuring hygienic usage with each application, while also reducing plastic waste compared to conventional monodose solutions. Moreover, it remains compatible with existing treatments and packaging processes.

In April 2023, the Nirma Group acquired Stericon Pharma Pvt. Ltd. for an undisclosed sum. This acquisition marks a strategic move by the Nirma Group to leverage synergies between the companies, accessing new markets, technologies, and capabilities. The objective is to strengthen the group's presence in the contract development and manufacturing organization (CDMO) sector, as well as enhance its current healthcare portfolio. Stericon Pharma Pvt. Ltd., an Indian-based pharmaceutical manufacturing company specializing in eye dropper production, brings valuable expertise to the Nirma Group.

Major companies operating in the ophthalmic eye dropper market are Pfizer Inc., AbbVie Inc., Novartis AG, Alcon Inc., Bausch & Lomb Incorporated, Rexam Healthcare Packaging Inc., Intas Pharmaceuticals Ltd., AptarGroup Inc, Cipla Ltd, Gerresheimer AG, Lupin Ltd., Santen Pharmaceutical Co Ltd., Rohto Pharmaceutical Co Ltd., Silgan Dispensing Systems, Akorn Operating Company LLC, Nemera Development S.A., Ajanta Pharma Ltd., Perrigo Company plc, Bora Pharmaceuticals Co Ltd., Sun Pharmaceutical Industries Limited, Flagship Biotech International Private Limited, PanOptica Inc., SAS Yslab

North America was the largest region in the ophthalmic eye dropper market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ophthalmic eye dropper market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ophthalmic eye dropper market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The ophthalmic eye dropper market consists of sales of visine advanced relief, systane ultra lubricant, refresh optical lubricant, clear eyes maximum redness relief, and blink tears lubricating eye drops. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ophthalmic Eye Dropper Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ophthalmic eye dropper market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ophthalmic eye dropper ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ophthalmic eye dropper market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Eye Dropper: Unidose Eye Dropper; Preserved Multi-Dose Eye Dropper; Preservative-Free Multi-Dose Eye Dropper
• 2) By Drug Type: Prescription Drugs; Over-The-Counter (OTC) Drugs
• 3) By Treatment Type: Dry Eye; Glaucoma; Allergies; Conjunctivitis; Other Treatment Type
• 4) By End-Use: Hospitals; Ophthalmic Centers; Homecare Settings; Other End-Users
• Subsegments:
• 1) By Unidose Eye Dropper: Single Use Containers; Disposable Dropper Systems
• 2) By Preserved Multi-Dose Eye Dropper: Eye Droppers With Preservative Solutions; Multi-Dose Containers With Built-In Preservation
• 3) By Preservative-Free Multi-Dose Eye Dropper: Multi-Dose Containers Without Preservatives; Non-Preserved, Sterile Eye Drop Systems
• Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Novartis AG; Alcon Inc.; Bausch & Lomb Incorporated
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ophthalmic Eye Dropper Market Characteristics

3. Ophthalmic Eye Dropper Market Trends And Strategies

4. Ophthalmic Eye Dropper Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Ophthalmic Eye Dropper Growth Analysis And Strategic Analysis Framework

• 5.1. Global Ophthalmic Eye Dropper PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Ophthalmic Eye Dropper Market Growth Rate Analysis
• 5.4. Global Ophthalmic Eye Dropper Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Ophthalmic Eye Dropper Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Ophthalmic Eye Dropper Total Addressable Market (TAM)

6. Ophthalmic Eye Dropper Market Segmentation

• 6.1. Global Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Unidose Eye Dropper
• Preserved Multi-Dose Eye Dropper
• Preservative-Free Multi-Dose Eye Dropper
• 6.2. Global Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription Drugs
• Over-The-Counter (OTC) Drugs
• 6.3. Global Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dry Eye
• Glaucoma
• Allergies
• Conjunctivitis
• Other Treatment Type
• 6.4. Global Ophthalmic Eye Dropper Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ophthalmic Centers
• Homecare Settings
• Other End-Users
• 6.5. Global Ophthalmic Eye Dropper Market, Sub-Segmentation Of Unidose Eye Dropper, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Use Containers
• Disposable Dropper Systems
• 6.6. Global Ophthalmic Eye Dropper Market, Sub-Segmentation Of Preserved Multi-Dose Eye Dropper, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Eye Droppers With Preservative Solutions
• Multi-Dose Containers With Built-In Preservation
• 6.7. Global Ophthalmic Eye Dropper Market, Sub-Segmentation Of Preservative-Free Multi-Dose Eye Dropper, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Multi-Dose Containers Without Preservatives
• Non-Preserved, Sterile Eye Drop Systems

7. Ophthalmic Eye Dropper Market Regional And Country Analysis

• 7.1. Global Ophthalmic Eye Dropper Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Ophthalmic Eye Dropper Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ophthalmic Eye Dropper Market

• 8.1. Asia-Pacific Ophthalmic Eye Dropper Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ophthalmic Eye Dropper Market

• 9.1. China Ophthalmic Eye Dropper Market Overview
• 9.2. China Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ophthalmic Eye Dropper Market

• 10.1. India Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ophthalmic Eye Dropper Market

• 11.1. Japan Ophthalmic Eye Dropper Market Overview
• 11.2. Japan Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ophthalmic Eye Dropper Market

• 12.1. Australia Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ophthalmic Eye Dropper Market

• 13.1. Indonesia Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ophthalmic Eye Dropper Market

• 14.1. South Korea Ophthalmic Eye Dropper Market Overview
• 14.2. South Korea Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ophthalmic Eye Dropper Market

• 15.1. Western Europe Ophthalmic Eye Dropper Market Overview
• 15.2. Western Europe Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ophthalmic Eye Dropper Market

• 16.1. UK Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ophthalmic Eye Dropper Market

• 17.1. Germany Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ophthalmic Eye Dropper Market

• 18.1. France Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ophthalmic Eye Dropper Market

• 19.1. Italy Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ophthalmic Eye Dropper Market

• 20.1. Spain Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ophthalmic Eye Dropper Market

• 21.1. Eastern Europe Ophthalmic Eye Dropper Market Overview
• 21.2. Eastern Europe Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ophthalmic Eye Dropper Market

• 22.1. Russia Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ophthalmic Eye Dropper Market

• 23.1. North America Ophthalmic Eye Dropper Market Overview
• 23.2. North America Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ophthalmic Eye Dropper Market

• 24.1. USA Ophthalmic Eye Dropper Market Overview
• 24.2. USA Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ophthalmic Eye Dropper Market

• 25.1. Canada Ophthalmic Eye Dropper Market Overview
• 25.2. Canada Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ophthalmic Eye Dropper Market

• 26.1. South America Ophthalmic Eye Dropper Market Overview
• 26.2. South America Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ophthalmic Eye Dropper Market

• 27.1. Brazil Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ophthalmic Eye Dropper Market

• 28.1. Middle East Ophthalmic Eye Dropper Market Overview
• 28.2. Middle East Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ophthalmic Eye Dropper Market

• 29.1. Africa Ophthalmic Eye Dropper Market Overview
• 29.2. Africa Ophthalmic Eye Dropper Market, Segmentation By Eye Dropper, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Ophthalmic Eye Dropper Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Ophthalmic Eye Dropper Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ophthalmic Eye Dropper Market Competitive Landscape And Company Profiles

• 30.1. Ophthalmic Eye Dropper Market Competitive Landscape
• 30.2. Ophthalmic Eye Dropper Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Alcon Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bausch & Lomb Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Ophthalmic Eye Dropper Market Other Major And Innovative Companies

• 31.1. Rexam Healthcare Packaging Inc.
• 31.2. Intas Pharmaceuticals Ltd.
• 31.3. AptarGroup Inc
• 31.4. Cipla Ltd
• 31.5. Gerresheimer AG
• 31.6. Lupin Ltd.
• 31.7. Santen Pharmaceutical Co Ltd.
• 31.8. Rohto Pharmaceutical Co Ltd.
• 31.9. Silgan Dispensing Systems
• 31.10. Akorn Operating Company LLC
• 31.11. Nemera Development S.A.
• 31.12. Ajanta Pharma Ltd.
• 31.13. Perrigo Company plc
• 31.14. Bora Pharmaceuticals Co Ltd.
• 31.15. Sun Pharmaceutical Industries Limited

32. Global Ophthalmic Eye Dropper Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ophthalmic Eye Dropper Market

34. Recent Developments In The Ophthalmic Eye Dropper Market

35. Ophthalmic Eye Dropper Market High Potential Countries, Segments and Strategies

• 35.1 Ophthalmic Eye Dropper Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Ophthalmic Eye Dropper Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Ophthalmic Eye Dropper Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer